Epstein-Barr virus BRLF1 inhibits transcription of IRF3 and IRF7 and suppresses induction of interferon-β

被引:68
作者
Bentz, Gretchen L. [1 ]
Liu, Renshui [1 ]
Hahn, Angela M.
Shackelford, Julia [1 ,3 ]
Pagano, Joseph S. [1 ,2 ]
机构
[1] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Med & Microbiol & Immunol, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Dept Cellular Biol, Chapel Hill, NC 27599 USA
关键词
Epstein-Barr virus; Rta; BRLF1; Type I interferons; Antiviral response; Interferon Regulatory Factor; IRF3; IRF5; IRF7; Immune response; HERPES-SIMPLEX-VIRUS; IMMEDIATE-EARLY PROTEIN; TOLL-LIKE RECEPTORS; LYTIC CYCLE GENES; STIMULATED GENES; RTA PROTEIN; DNA-BINDING; REGULATORY FACTOR-7; SIGNAL-TRANSDUCTION; PROMOTER ACTIVITY;
D O I
10.1016/j.virol.2010.03.014
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Activation of interferon regulatory factors (IRFs) 3 and 7 is essential for the induction of Type I interferons (IFN) and innate antiviral responses, and herpesviruses have evolved mechanisms to evade such responses. We previously reported that Epstein-Barr virus BZLE1, an immediate-early (IE) protein, inhibits the function of IRF7, but the role of BRLF1, the other IE transactivator, in IRE regulation has not been examined. We now show that BRLF1 expression decreased induction of IFN-beta, and reduced expression of IRF3 and IRF7; effects were dependent on N- and C-terminal regions of BRLF1 and its nuclear localization signal. Endogenous IRF3 and IRF7 RNA and protein levels were also decreased during cytolytic EBV infection. Finally, production of IFN-beta was decreased during lytic EBV infection and was associated with increased susceptibility to superinfection with Sendai virus. These data suggest a new role for BRLF1 with the ability to evade host innate immune responses. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:121 / 128
页数:8
相关论文
共 68 条
[1]   Major human cytomegalovirus structural protein pp65 (ppUL83) prevents interferon response factor 3 activation in the interferon response [J].
Abate, DA ;
Watanabe, S ;
Mocarski, ES .
JOURNAL OF VIROLOGY, 2004, 78 (20) :10995-11006
[2]   The ABCs of immunology:: Structure and function of TAP, the transporter associated with antigen processing [J].
Abele, R ;
Tampé, R .
PHYSIOLOGY, 2004, 19 :216-224
[3]   Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases [J].
Adamson, AL ;
Darr, D ;
Holley-Guthrie, E ;
Johnson, RA ;
Mauser, A ;
Swenson, J ;
Kenney, S .
JOURNAL OF VIROLOGY, 2000, 74 (03) :1224-1233
[4]   MAVS Dimer Is a Crucial Signaling Component of Innate Immunity and the Target of Hepatitis C Virus NS3/4A Protease [J].
Baril, Martin ;
Racine, Marie-Eve ;
Penin, Francois ;
Lamarre, Daniel .
JOURNAL OF VIROLOGY, 2009, 83 (03) :1299-1311
[5]   On the role of IRF in host defense [J].
Barnes, B ;
Lubyova, B ;
Pitha, PM .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2002, 22 (01) :59-71
[6]   Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection [J].
Barnes, BJ ;
Richards, J ;
Mancl, M ;
Hanash, S ;
Beretta, L ;
Pitha, PM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (43) :45194-45207
[7]   The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3 [J].
Basler, CF ;
Mikulasova, A ;
Martinez-Sobrido, L ;
Paragas, J ;
Mühlberger, E ;
Bray, M ;
Klenk, HD ;
Palese, P ;
García-Sastre, A .
JOURNAL OF VIROLOGY, 2003, 77 (14) :7945-7956
[8]   Post-translational modification of Rta of Epstein-Barr virus by SUMO-1 [J].
Chang, LK ;
Lee, YH ;
Cheng, TS ;
Hong, YR ;
Lu, PJ ;
Wang, JJ ;
Wang, WH ;
Kuo, CW ;
Li, SSL ;
Liu, ST .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (37) :38803-38812
[9]   Epstein-Barr virus immediate-early protein BRLF1 induces the lytic form of viral replication through a mechanism involving phosphatidylinositol-3 kinase activation [J].
Darr, CD ;
Mauser, A ;
Kenney, S .
JOURNAL OF VIROLOGY, 2001, 75 (13) :6135-6142
[10]   Interferon regulatory factor 1 tryptophan 11 to arginine point mutation abolishes DNA binding [J].
Eason, DE ;
Shepherd, AT ;
Blanck, G .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1999, 1446 (1-2) :140-144